Orthofix Medical Inc. OFIX Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax at other companies
Other financials
Where this comes from
Reported directly by Orthofix Medical Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax.
The official record: Orthofix Medical Inc.’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Orthofix Medical Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Orthofix Medical Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax?
- Orthofix Medical Inc. (OFIX) reported other comprehensive income unrealized holding gain loss on securities arising during period before tax of $1.67M in Q1 2024.
- How has Orthofix Medical Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax changed year-over-year?
- Orthofix Medical Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax increased by 2752.4% year-over-year, from -$63K to $1.67M.
- What is the long-term trend for Orthofix Medical Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax?
- Over 2 years (2021 to 2023), Orthofix Medical Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period before tax has grown at a 19.0% compound annual growth rate (CAGR), from -$942K to -$1.33M.
- What does other comprehensive income unrealized holding gain loss on securities arising during period before tax mean?
- This metric captures the change in the fair value of available-for-sale securities or other financial instruments that have not yet been realized through a sale. It reflects market-driven fluctuations in the value of investment portfolios that are excluded from net income under current accounting standards. Tracking this provides insight into the unrealized gains or losses embedded within the company's balance sheet assets.